Search Results 461-470 of 17406 for prednisone

  1. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

    Patients should be excluded if they have a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or ...

  2. Scalp psoriasis vs. seborrheic dermatitis: What's the difference? - Mayo Clinic

    Prednisone risks, benefits · Pregnancy and breastfeeding when you have psoriasis · Psoriasis · Psoriasis and clinical trials · Psoriasis and intimacy ...

  3. Childhood asthma - Diagnosis & treatment - Mayo Clinic

    Examples include prednisone and methylprednisolone. They can cause serious side effects when used long term, so they're only used to treat severe asthma ...

  4. Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Currently receiving treatment with aminosalisylate, prednisone, or budesonide. Key Exclusion Criteria: Diagnosis of Crohn's disease or indeterminate colitis ...

  5. Delafloxacin (intravenous route) - Mayo Clinic

    The risk of having tendon problems may be increased if you are over 60 years of age, are using steroid medicines (eg, dexamethasone, prednisolone, prednisone ...

  6. A Study of Fresolimumab in Patients with Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS) - Mayo Clinic

    The patient has been taking prednisone at a dose > 10 mg/day (or equivalent dose of an alternative glucocorticoid) within 4 weeks prior to Visit 1 (Screening ...

  7. 2 22 Poland audio_only

    The strict data are when you exceed a dose the equivalent of 40 milligrams of oral prednisone. ... prednisone, that's when we begin to worry not talking ...

  8. Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy - Mayo Clinic

    Chronic oral prednisone or prednisolone therapy for at least 6 continuous months directly preceding Visit 1, and on a stable dose for at least one month prior ...

  9. Clinical trials - Oncology (Medical)

    ... prednisone, thioguanine, vincristine, and pegaspargase work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping ...

  10. A Study to Evaluate the Safety, Tolerability, and Determine the Optimal Dose for the Expansion Cohorts of VSV-IFNβ-NIS in Combination with Pembrolizumab in Patients with Refractory Solid Tumors - Mayo Clinic

    prednisone or equivalent within 1 week prior to planned start of study treatment - History of severe immune-mediated adverse reaction to immune checkpoint ...